Development of Mupirocin Resistance among Methicillin-Resistant Staphylococcus aureus after Widespread Use of Nasal Mupirocin Ointment
- 1 December 1996
- journal article
- Published by Cambridge University Press (CUP) in Infection Control & Hospital Epidemiology
- Vol. 17 (12), 811-813
- https://doi.org/10.2307/30141176
Abstract
All methicillin-resistant Staphylococcus aureus (MRSA) strains isolated from colonized or infected patients in a 625-bed public teaching hospital during an epidemic, and for 3 years thereafter, underwent susceptibility testing to mupirocin. Mupirocin resistance among MRSA increased markedly over this period (1990, 2.7%; 1991, 8.0%; 1992, 61.5%; 1993, 65%) in association with increased use of mupirocin ointment as an adjunct to infection control measures.Keywords
This publication has 12 references indexed in Scilit:
- Mupirocin Resistance: Clinical and Molecular EpidemiologyInfection Control & Hospital Epidemiology, 1995
- Detection and characterization of mupirocin resistance in Staphylococcus aureusAntimicrobial Agents and Chemotherapy, 1993
- Mupirocin susceptibility in vitro and nasal eradication of epidemic methicillin-resistant Staphylococcus aureusJournal of Hospital Infection, 1993
- Methicillin-Resistant Staphylococcus aureus in Hospitals and Long-Term Care Facilities: Microbiology, Epidemiology, and Preventive MeasuresInfection Control & Hospital Epidemiology, 1992
- Mupirocin resistanceThe Lancet, 1991
- Mupirocin-resistant Staphylococcus aureusThe Lancet, 1990
- Elimination of nasal carriage of methicillin-resistant Staphylococcus aureus with mupirocin during a hospital outbreakJournal of Antimicrobial Chemotherapy, 1988
- MUPIROCIN-RESISTANT STAPHYLOCOCCUS AUREUSThe Lancet, 1987
- MUPIROCIN-RESISTANT STAPHYLOCOCCUS AUREUSThe Lancet, 1987
- Elimination of nasal carriage of Staphylococcus aureus with mupirocin (‘pseudomonic acid’)—a controlled trialJournal of Antimicrobial Chemotherapy, 1986